Marshall Wace’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Sell |
1,297,752
-312,956
| -19% | -$2.91M | 0.01% | 699 |
|
|
2025
Q1 | $10.8M | Buy |
1,610,708
+394,526
| +32% | +$2.66M | 0.01% | 682 |
|
|
2024
Q4 | $12.9M | Sell |
1,216,182
-251,228
| -17% | -$2.67M | 0.02% | 646 |
|
|
2024
Q3 | $21.5M | Sell |
1,467,410
-245,915
| -14% | -$3.6M | 0.03% | 443 |
|
|
2024
Q2 | $20.7M | Buy |
1,713,325
+1,191,774
| +229% | +$14.4M | 0.03% | 439 |
|
|
2024
Q1 | $12.9M | Buy |
+521,551
| New | +$12.9M | 0.02% | 581 |
|
|
2022
Q1 | – | Sell |
-10,654
| Closed | -$138K | – | 2918 |
|
|
2021
Q4 | $138K | Buy |
10,654
+2,306
| +28% | +$29.9K | ﹤0.01% | 2604 |
|
|
2021
Q3 | $203K | Buy |
+8,348
| New | +$203K | ﹤0.01% | 2207 |
|